2019
DOI: 10.1016/j.cmi.2018.11.026
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological and molecular characterization of a Trichophyton tonsurans epidemic in schools of a city in the northern suburbs of Paris, France

Abstract: received a report regarding a possible epidemic of dermatophytosis in a school group from Clichysous-Bois (in the northern suburbs of Paris). All the children of this school group were screened for dermatophytosis by clinical and mycological examinations. During the 15 months following this first report, children from eight other schools in this city, and members of their families, came to the same ParasitologyeMycology department for dermatophytosis screening. The main goal of this investigation was to identi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…In children, tinea capitis (TC) is the most frequent fungal infection and a widespread health problem all over the world. Over the past decade, TC of anthropophilic origin has significantly increased, particularly in urban areas, leading to epidemics in children’s communities [ 2 , 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…In children, tinea capitis (TC) is the most frequent fungal infection and a widespread health problem all over the world. Over the past decade, TC of anthropophilic origin has significantly increased, particularly in urban areas, leading to epidemics in children’s communities [ 2 , 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Trichophyton tonsurans is associated with both tinea capitis, the most common superficial mycosis in school-age-children, and tinea corporis (Vingataramin et al, 2019). The clinical manifestations are variable from asymptomatic carriers to patients with inflammatory manifestations (Shimoyama et al, 2016).…”
mentioning
confidence: 99%